Abstract
MOUSE lymphomas, such as 6C3HED, undergo complete regression after one or more injections of L-asparaginase1, and remissions have been reported in some patients with acute leukaemia after treatment with L-asparaginase2–4. Roberts et al.5 found that purified bacterial L-glutaminase inhibited the growth of Ehrlich mouse carcinoma. Before considering this enzyme for therapeutic studies in man, it is necessary to study in vitro effects of the enzyme on human blood cells. Previous work6 demonstrated that the cells of 6C3HED lymphoma do not survive incubation with very low concentrations of L-asparaginase (1.7 mIU/ml.), while the cells of the in vivo resistant variant of 6C3HED were not killed by 170 mIU of enzyme/ml. The blood lymphocytes from patients with chronic lymphocytic leukaemia were found to be more sensitive than normal lymphocytes to incubation with 170 mIU of L-asparaginase/ml. but not as sensitive as 6C3HED mouse lymphoma which responds in vivo to the enzyme. In this study, the slide chamber method7 was used to compare the sensitivity of normal and leukaemic lymphocytes to glutaminase.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
